| # | Drug | Count |
|---|---|---|
| 0 | FINGOLIMOD HCL | 34 |
| 1 | DALFAMPRIDINE | 22 |
| 2 | RITUXIMAB | 20 |
| 3 | GABAPENTIN | 15 |
| 4 | OCRELIZUMAB | 15 |
| 5 | METHYLPREDNISOLONE | 14 |
| 6 | PANTOPRAZOLE | 11 |
| 7 | ALEMTUZUMAB | 9 |
| 8 | BACLOFEN | 9 |
| 9 | CYCLOSPORINE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LANOLIN, PETROLATUM | 1 | 0.0040 |
| 1 | LANOLIN AND PETROLATUM | 1 | 0.0038 |
| 2 | MARAVIROC | 3 | 0.0013 |
| 3 | DEFEROXAMINE MESYLATE | 2 | 0.0009 |
| 4 | RILPIVIRINE | 5 | 0.0007 |
| 5 | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B | 1 | 0.0006 |
| 6 | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | 1 | 0.0006 |
| 7 | DAUNORUBICIN HYDROCHLORIDE | 1 | 0.0006 |
| 8 | ETRASIMOD | 1 | 0.0006 |
| 9 | RALTEGRAVIR | 3 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 3 | 0.0013 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 9 | 0.0005 |
| 2 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 7 | 0.0003 |
| 4 | Potassium Channel Blocker [EPC] | 22 | 0.0003 |
| 5 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0002 |
| 6 | Barbiturate [EPC] | 2 | 0.0002 |
| 7 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 8 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 2 | 0.0001 |
| 9 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |